|
Post by akemp3000 on Aug 10, 2016 13:01:24 GMT -5
Absolutely. The great Peter Lynch said, ""Your ultimate success or failure will depend on your ability to ignore the worries of the world long enough to allow your investments to succeed". Granted this ride has been long and painful but it sure seems like the diabetes world is about to finally catch up with TS science at which time, Wall Street will follow. Most importantly, my dad and millions of other diabetics can soon reap the joy of an improved quality of life with Afrezza. I am optimistic the ride up will be MUCH greater than the painful ride down
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 10, 2016 13:07:16 GMT -5
Absolutely. The great Peter Lynch said, ""Your ultimate success or failure will depend on your ability to ignore the worries of the world long enough to allow your investments to succeed". Granted this ride has been long and painful but it sure seems like the diabetes world is about to finally catch up with TS science at which time, Wall Street will follow. Most importantly, my dad and millions of other diabetics can soon reap the joy of an improved quality of life with Afrezza. I am optimistic the ride up will be MUCH greater than the painful ride down is your dad on Afrezza?
|
|
|
Post by audiomr on Aug 10, 2016 15:15:21 GMT -5
We've waited a very long time for the turn that many of us have long sought. We know the product is amazing yet the results to date have been horrible up to and including the start of the 2.0 launch which wasn't a surprise. Mike C explained why scripts were relatively flat last week which was based on the one-time changeover in supply to MNKD branded Afrezza and the related computer systems at distributors needing to reflect this. Matt said previously it would be August and September when scripts would begin rising. We could be at the very end of a long struggle and low share price. I cannot wait to see script results in the next several Fridays and what happens to the pps. There are many who think this will take much longer to make the turn. I don't. I have followed this journey for years and believe the turn starts now...all IMHO. Agreed. I have been in this investment for a long time and after reading the transcript from the call yesterday, I feel more positive than ever. Getting control was key. The Sanofi deal was destined to fail from the start as the reps were still selling the old technology which was paying the mortgage. Its exactly why Tesla motors didn't allow the existing dealer network sell their cars. the existing dealers were not familiar with electric cars and it was harder to sell, so why not sell a gas car. When disrupting the market, you cannot rely on the old guard to push for the new. Heck its human nature. so now that we have a dedicated sales force, who only gets paid with the sale of afrezza, we will see exponential growth in sales in the coming months. as crazy as this sounds, i think its time to add to position. I think Tesla's decision was more about startup cost. If it set up a dealer network it would train the salespeople in how to sell its cars, which would be all they'd be handling. More of an issue for manufacturers who make a couple of electric models in an otherwise conventional lineup (Nissan, for example, or Chevy). Sanofi could have sold Afrezza effectively if it had cared to make the effort.
|
|
|
Post by LosingMyBullishness on Aug 10, 2016 21:00:55 GMT -5
In my opinion a small difference in script numbers of just 20 this week will make a real difference right now. Imagine the scripts go back to 101 or alternatively to 141 this Friday. This could make a difference of 0.8 compared to 1.2 in share price.
|
|
|
Post by LosingMyBullishness on Aug 10, 2016 21:13:08 GMT -5
In my opinion a small difference in script numbers of just 20 this week will make a real difference right now. Imagine the scripts go back to 101 or alternatively to 141 this Friday. This could make a difference of 0.8 compared to 1.2 in share price. Or stated differently: this is the time when one single doctor can theoretically make a hell lot of money..
|
|
|
Post by rossomalley on Aug 10, 2016 22:34:16 GMT -5
In my opinion a small difference in script numbers of just 20 this week will make a real difference right now. Imagine the scripts go back to 101 or alternatively to 141 this Friday. This could make a difference of 0.8 compared to 1.2 in share price. I shudder to think where share price will be on Monday if NRx goes down to 101 on Friday!
|
|
|
Post by vestful on Aug 10, 2016 23:31:38 GMT -5
All-be-it an extremely small data sample lets hope the copay enrollment chart is telling of where the scripts are headed.
|
|
|
Post by agedhippie on Aug 11, 2016 8:42:12 GMT -5
In my opinion a small difference in script numbers of just 20 this week will make a real difference right now. Imagine the scripts go back to 101 or alternatively to 141 this Friday. This could make a difference of 0.8 compared to 1.2 in share price. I shudder to think where share price will be on Monday if NRx goes down to 101 on Friday! The share price will be exactly where it is today. At this time provided there is no huge movement an increase or decrease is not going to matter. I think we will get back to where we were with NRx at the peak of Sanofi sales by the end of October with the share price hitting $2 and that is when sales really start to matter.
|
|
|
Post by slugworth008 on Aug 11, 2016 22:29:09 GMT -5
I bought some more today, at 92 cents. Sure seemed like a bargain after listening to the CC yesterday. Yeah - I piled on as well.
|
|
|
Post by akemp3000 on Aug 12, 2016 9:51:59 GMT -5
Does anyone know today's script report?
|
|
|
Post by LosingMyBullishness on Aug 12, 2016 11:51:04 GMT -5
Does anyone know today's script report? 117 NRx are not impressive.
|
|
|
Post by kdaddyfresh2000 on Aug 12, 2016 11:58:10 GMT -5
Does anyone know today's script report? 117 NRx are not impressive. No, they are not. I would be much more patient but-for the repeated but unfounded reassurances that investors were subjected to in the past by Hakan and Matt. The transition to Mannkind was complete last week. That should not be the reason for the flat numbers. Venting again.
|
|
|
Post by peppy on Aug 12, 2016 12:07:11 GMT -5
|
|
|
Post by als57 on Aug 12, 2016 12:10:19 GMT -5
Almost unbelievable what the company had earlier endured with the leadership that was in place and the boldfaced exaggerations of business opportunities. So with that, I wholeheartedly agree with your view on Hakan and Matt.
|
|
|
Post by dictatorsaurus on Aug 12, 2016 12:16:26 GMT -5
Scripts are rising at lightening speed. 1 extra NRx this week.
|
|